PRC
CCXI

Pearl River Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Pearl River Capital’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,991
Closed -$256K – 623
2021
Q1 		$256K Sell
4,991
-204
-4% -$12.3K 0.08% 322
2020
Q4 		$322K Sell
5,195
-118
-2% -$6.76K 0.12% 262
2020
Q3 		$291K Buy
+5,313
New +$286K 0.12% 263

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pearl River Capital's CCXI Position: Q2 2021 in Review

Pearl River Capital sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 4,991 shares — an estimated $256K sold.

Pearl River Capital first reported a position in CCXI in Q3 2020 and held it in 3 quarters. The position peaked at $322K in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Pearl River Capital reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Pearl River Capital sold 4,991 ChemoCentryx, Inc. shares in Q2 2021, an estimated $256K.
  • Pearl River Capital first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 3 quarters.
  • Pearl River Capital's ChemoCentryx, Inc. position peaked at $322K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Pearl River Capital's 13F filing for Q2 2021, filed 13 Aug 2021.